Suchergebnisse - "Dougados, Maxime"

PubPharm (1.143)

31

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data

enthalten in: Arthritis Research & Therapy | 2023

von Granados, R. | Ladehesa-Pineda, M. | Puche-Larrubia, M. | +4

32

Efficacy and safety of bimekizumab in axial spondyloarthritis : results of two parallel phase 3 randomised controlled trials

enthalten in: Annals of the rheumatic diseases | 2023

von van der Heijde, D. | Deodhar, A. | Baraliakos, X. | +21

CommentIn: Nat Rev Rheumatol. 2023 Mar;19(3):127. - PMID 36755118

33

Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment

enthalten in: RMD open | 2023

von Vallier, M. | Segurens, B. | Larsonneur, E. | +7

34

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis : data from the ESPOIR cohort

enthalten in: Clinical and experimental rheumatology | 2023

von Guellec, D. | Carvajal-Alegria, G. | Daïen, C. | +13

35

Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice : results from a retrospective study (FORSYA)

enthalten in: RMD open | 2023

von Dougados, M. | Lucas, J. | Desfleurs, E. | +7

36

Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis

enthalten in: Clinical and experimental rheumatology | 2023

von Garofoli, R. | Resche-Rigon, M. | Roux, C. | +3

37

Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study

enthalten in: Seminars in arthritis and rheumatism | 2023

von Ladehesa-Pineda, M. | Ortega-Castro, R. | Puche-Larrubia, M. | +4

38

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease : a post hoc analysis from ORAL Surveillance

enthalten in: Annals of the rheumatic diseases | 2023

von Charles-Schoeman, C. | Buch, M. | Dougados, M. | +13

39

Real-world evidence of the use of the infliximab biosimilar SB2 : data from the PERFUSE study

enthalten in: Rheumatology advances in practice | 2023

von Fautrel, B. | Bouhnik, Y. | Dieude, P. | +5

40

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

enthalten in: Annals of the rheumatic diseases | 2023

von Dougados, M. | Charles-Schoeman, C. | Szekanecz, Z. | +13